Jeff S. Jasper
Myriad (Germany)(DE)Myriad Genetics(US)
Publications by Year
Research Areas
FOXO transcription factor regulation, Cancer Genomics and Diagnostics, Prostate Cancer Treatment and Research, Estrogen and related hormone effects, BRCA gene mutations in cancer
Most-Cited Works
- → 27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology(2013)825 cited
- → Systematic identification of signaling pathways with potential to confer anticancer drug resistance(2014)197 cited
- → ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer(2016)140 cited
- → The Metabolic Regulator ERRα, a Downstream Target of HER2/IGF-1R, as a Therapeutic Target in Breast Cancer(2011)135 cited
- → Obesity, Cholesterol Metabolism, and Breast Cancer Pathogenesis(2014)112 cited
- → The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer(2019)91 cited
- → Lysine-Specific Histone Demethylase 1 Inhibitors Control Breast Cancer Proliferation in ERα-Dependent and -Independent Manners(2012)76 cited
- → MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer(2016)64 cited
- → A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency(2021)58 cited
- → ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling(2016)53 cited